Home Research-feed Channel Rankings GCT THU AI TR Open Data Must Reading

views: 1

Jan H Nuijens

Pharming Technologies BV, Leiden, THE NETHERLANDS

Sign in to view more

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers5 papers

Sort

By YearBy Citation

Clinical Studies of Recombinant Human C1 Inhibitor (rhC1INH) in Patients with Acute Attacks of Hereditary Angioedema

J. Nuijens,R. Verdonk,B. Giannetti,S. Visscher,M. van Doorn,T. Resink,M. Levi,C. Hack,H. Farkas,K. Obtulowicz,T. Caballero,M. Cicardi

Journal of Allergy and Clinical Immunology, no. 3 (2008): 797-797

Cited by4EIBibtex

Clinical studies of recombinant human C1 inhibitor in subjects with hereditary angioedema

Jan H Nuijens,R. Verdonk,M. van Doorn,Koos J Burggraaf,Adam F Cohen,Goda Choi,Maarten R Soeters, Erik C Hack,Marcel Levi,E. Sisk,P. Pinciaro

The Journal of Allergy and Clinical Immunology, no. 2 (2005): S202-S202

Cited by7EIBibtex

A phase I study of recombinant human C1 inhibitor (RHC1INH) in asymptomatic patients with hereditary angioedema (HAE)

M VANDOORN,J NUIJENS,R SCHOEMAKER,K BURGGRAAF,A COHEN

Clinical Pharmacology & Therapeutics, no. 2 (2004)

Bibtex

Proteolytic inactivation of α1‐antitrypsin and α1‐antichymotrypsin by neutrophils in arthritic joints

J J Abbink,Angela M Kamp,J H Nuijens,Tom J G Swaak,C Erik Hack

Arthritis & Rheumatism, (1993)

Cited by25Bibtex

Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema

M Cugno,J Nuijens, E Hack,A Eerenberg,D Frangi,A Agostoni,M Cicardi

The Journal of clinical investigation, no. 4 (1990): 1215-1220

Cited by56WOSBibtex

View All

Base Info Papers Patents Projects